Xeris raises outlook despite posting $31.1 million loss
Executives argue the loss reflects a one-time accounting charge to clear outstanding debt rather than the drugmaker's performance.
Executives argue the loss reflects a one-time accounting charge to clear outstanding debt rather than the drugmaker's performance.
What's Your Reaction?
